Cargando…
A highly sensitive nanobody-based immunoassay detecting SARS-CoV-2 nucleocapsid protein using all-recombinant reagents
Antigen tests have been crucial for managing the COVID-19 pandemic by identifying individuals infected with SARS-CoV-2. This remains true even after immunity has been widely attained through natural infection and vaccination, since it only provides moderate protection against transmission and is hig...
Autores principales: | Segovia-de los Santos, Paula, Padula-Roca, Carolina, Simon, Ximena, Echaides, Cesar, Lassabe, Gabriel, Gonzalez-Sapienza, Gualberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10367427/ https://www.ncbi.nlm.nih.gov/pubmed/37497229 http://dx.doi.org/10.3389/fimmu.2023.1220477 |
Ejemplares similares
-
Nanobody-Based Blocking of Binding ELISA for the Detection of Anti-NS1 Zika-Virus-Specific Antibodies in Convalescent Patients
por: Delfin-Riela, Triana, et al.
Publicado: (2023) -
Recombinant Streptavidin Nanopeptamer Anti-Immunocomplex
Assay for Noncompetitive Detection
of Small Analytes
por: Carlomagno, Mariana, et al.
Publicado: (2014) -
Nanobody‑horseradish peroxidase and -EGFP fusions as reagents to detect porcine parvovirus in the immunoassays
por: Lu, Qizhong, et al.
Publicado: (2020) -
Shiga-Like Toxin B Subunit of Escherichia
coli as Scaffold for High-Avidity Display of Anti-immunocomplex
Peptides
por: Lassabe, Gabriel, et al.
Publicado: (2014) -
Recombinant nucleocapsid protein is potentially an inexpensive, effective serodiagnostic reagent for infectious bronchitis virus
por: Ndifuna, Abdul, et al.
Publicado: (1998)